MentalHealthDaily

Genetics of Female Reproductive Behaviors & Psychiatric Disorders: Age of First Sexual Intercourse Significant (2023 Study)

The complex interplay between reproductive behaviors and psychiatric disorders is an area of interest within the scientific community, revealing how our genetic makeup may influence both our reproductive milestones and mental health. A recent study sheds light on this relationship, focusing on the causal pathways linking reproductive behaviors, such as the age at first sexual …

Minocycline for PTSD: Inhibition of Fear Memory Retention via MMP-9 (2024 Study)

by GLOOM

Recent research has uncovered the potential of minocycline, a tetracycline antibiotic, in modifying fear memory retention. A new study conducted by Yanfang Xia and colleagues, published in Translational Psychiatry, highlights how minocycline could play a role in treating anxiety and stress-related disorders. Highlights: Study Basis: The study was based on Pavlovian fear conditioning as a …

Stellate Ganglion Block (SGB) for Anxiety Disorders: Preliminary Evidence (2023)

by GLOOM

Stellate Ganglion Block (SGB), a medical procedure originally designed for pain management, is emerging as a potential treatment for anxiety disorders. This approach leverages its ability to modulate the sympathetic nervous system, which plays a significant role in anxiety symptoms. Highlights: SGB Procedure & Technicality: SGB involves injecting a local anesthetic near the stellate ganglion …

Taking Lamictal (Lamotrigine) For Anxiety Disorders: Does It Help?

by GLOOM

Lamotrigine is a synthetic phenyltriazine chemical with anticonvulsant and analgesic properties initially sold by GlaxoSmithKline under the brand name Lamictal. It was first approved by the FDA in 1994 for the treatment of partial seizures in adults, and was subsequently approved in 1998 for the management of Lennox-Gastaut syndrome – a severe form of epilepsy …

Effexor (Venlafaxine) For Anxiety Disorders: An Effective Anxiolytic?

by GLOOM

Effexor (Venlafaxine) is a drug that was introduced in 1993 as a pharmaceutical antidepressant by Wyeth; its marketing rights are now owned by Pfizer. Pharmacodynamically, it functions primarily as a serotonin-norepinephrine reuptake inhibitor (SNRI) and is understood to be the first-ever “dual reuptake inhibitor” approved by the FDA for the treatment of major depressive disorder. …

What is Equine Therapy? Exploring Benefits of Human-Horse Relationships

by GLOOM

Many people find recreational horseback riding pleasurable and relaxing. However, many individuals are unaware that there’s a therapeutic form of horseback riding [often integrated with psychotherapy] called “equine assisted therapy.” In recent years equine therapy has garnered attention as a potential intervention for the treatment of PTSD, troubled youth, and even autism spectrum disorders. From …

EMDR Therapy For PTSD (Eye Movement Desensitization & Reprocessing)

by GLOOM

In the 1980s, a literature professor named Francine Shapiro had received a diagnosis of cancer, triggering significant psychological shock. Anyone diagnosed with a life-threatening condition like cancer may be unable to cope with the stress that accompanies the diagnosis. When the stress following an event (in the case of Francine it was a diagnosis) becomes …